NCT07042737Not yet recruiting
The Effect of Animation-Based Education on Menopausal Women's Attitudes, Behaviors, and Screening Test Participation Regarding Breast Cancer
The Effect of Education Provided to Women in Menopause Through Animation on Breast Cancer Attitudes, Behaviors, and Screening Test Participation
Source: ClinicalTrials.gov · Last updated 29 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study was to determine the effect of education provided to women in menopause through animation on their attitudes toward breast cancer, behaviors, and screening test participation. The study will include a total of 136 women in the menopausal period, comprising 68 experimental group participants and 68 control group participants who have applied to the Orduyeri and Kırtepe Family Health Centers affiliated with the Bartın Public Health Institution. Women who agree to participate in the project, which will run from January to August 2025, will receive 40-45 minute training sessions in a suitable room at the ASM. The training sessions will be conducted in groups of 8-12 people. The training content will include information about the purpose, duration, and rules of the training. After providing information about the project, a pre-test will be administered. Through face-to-face interviews, researchers assigned to the project will show animated videos enriched with sound and images via an online program they have prepared. These videos will be 10-12 minutes long, and an interim test will be conducted. Three months after the pre-test, the women participating in the study will be contacted, and a final test will be administered in their own homes. Project data will be collected using the Personal Information Form, Champion Health Belief Scale, and Breast Cancer Awareness Scale. Descriptive statistics, independent sample t-tests, chi-square tests, and repeated measures analysis of variance (ANOVA) tests will be used in the statistical analysis of the project.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 136 (estimated)
- First submitted
- 20 Jun 2025
- Start date
- 20 Jun 2025
- Primary completion date
- 31 Jul 2025
- Lead sponsor
- Inonu University
- Diseases
- Childhood cancers
- NCT number
- NCT07042737
What you commit to
- Study type: Interventional
- Planned participants: 136
- From 20 Jun 2025 to the primary completion date, 31 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- undergoing surgical menopause,
- currently or previously using hormonal therapy,
Other illness
- having a psychiatric disorder,
Other
- never experiencing menopausal symptoms,
- having menstruated in the past year,
- incomplete forms,
- not fully participating in video-based education programs.
Who the study is looking for
- Not having been diagnosed with breast cancer,
- not performing regular self-examinations (those who performed self-examinations at least once a month were excluded),
- not having had a mammogram (those who had a mammogram within the first six months after training were excluded),
- not having undergone a clinical breast examination (those who underwent a clinical breast examination within the first 6 months after the training were excluded),
- not breastfeeding or being pregnant, being literate, owning a smartphone,
- having internet access,
- not having uterine abnormalities,
- having ovaries,
- not having used sex hormones.
Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Inonu University Coordinator of this site? Confirm its status | Bartın | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.